# A Pilot Study of Rosiglitazone in the Treatment of GH Secreting Pituitary Adenomas

> **NCT03309319** · NA · UNKNOWN · sponsor: **Zhaoyun Zhang** · enrollment: 24 (estimated)

## Conditions studied

- Pituitary Tumor

## Interventions

- **DRUG:** Rosiglitazone

## Key facts

- **NCT ID:** NCT03309319
- **Lead sponsor:** Zhaoyun Zhang
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2016-10-16
- **Primary completion:** 2018-12-31
- **Final completion:** 2018-12-31
- **Target enrollment:** 24 (ESTIMATED)
- **Last updated:** 2017-10-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03309319

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03309319, "A Pilot Study of Rosiglitazone in the Treatment of GH Secreting Pituitary Adenomas". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT03309319. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*